PetMed Express, Inc.
PETS
$2.74
-$0.01-0.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 226.97M | 240.04M | 252.37M | 263.80M | 274.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 226.97M | 240.04M | 252.37M | 263.80M | 274.10M |
| Cost of Revenue | 157.84M | 165.55M | 174.91M | 183.59M | 189.33M |
| Gross Profit | 69.14M | 74.49M | 77.46M | 80.21M | 84.77M |
| SG&A Expenses | 69.91M | 64.70M | 70.11M | 72.77M | 84.34M |
| Depreciation & Amortization | 7.04M | 6.86M | 7.04M | 7.10M | 7.06M |
| Other Operating Expenses | -1.18M | -1.09M | -1.09M | -1.09M | -1.09M |
| Total Operating Expenses | 233.61M | 236.02M | 250.98M | 262.38M | 279.64M |
| Operating Income | -6.64M | 4.02M | 1.40M | 1.43M | -5.54M |
| Income Before Tax | -587.00K | 1.92M | -488.00K | -133.00K | -6.27M |
| Income Tax Expenses | 5.68M | 1.56M | 475.00K | 2.44M | 1.19M |
| Earnings from Continuing Operations | -6.27 | 0.36 | -0.96 | -2.57 | -7.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.27M | 357.00K | -963.00K | -2.57M | -7.46M |
| EBIT | -6.64M | 4.02M | 1.40M | 1.43M | -5.54M |
| EBITDA | 401.00K | 9.88M | 7.44M | 7.53M | 514.00K |
| EPS Basic | -0.30 | 0.02 | -0.05 | -0.13 | -0.37 |
| Normalized Basic EPS | -0.17 | 0.16 | 0.09 | 0.09 | -0.11 |
| EPS Diluted | -0.31 | 0.01 | -0.06 | -0.14 | -0.38 |
| Normalized Diluted EPS | -0.18 | 0.16 | 0.08 | 0.08 | -0.11 |
| Average Basic Shares Outstanding | 82.38M | 82.19M | 81.98M | 81.76M | 81.58M |
| Average Diluted Shares Outstanding | 83.15M | 82.96M | 82.75M | 82.59M | 81.98M |
| Dividend Per Share | -- | 0.00 | 0.00 | 0.30 | 0.60 |
| Payout Ratio | -2.89% | 54.34% | -21.60% | -250.16% | -166.63% |